Halozyme Therapeutics (HALO) Stock Chart & Stock Price History $54.17 +0.62 (+1.15%) As of 02:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Halozyme Therapeutics Stock Price Performance The Halozyme Therapeutics (HALO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.16%, with a year-to-date return of 13.14%. In the past month, the stock has decreased 8.90%, reflecting recent market activity. As of the latest close, Halozyme Therapeutics traded at $53.55 with a market cap of $6.60 billion and volume of 1.96 million shares. Five years ago, the stock traded at $23.26, representing a 132.56% increase over that period. At the time, it had a market cap of $3.14 billion and a volume of 1.45 million shares. Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.37%1 Month Performance-8.90%3 Month Performance-10.07%Year-To-Date Performance+13.14%1 Year Performance+5.16%5 Year Performance+132.56% HALO Stock Chart for Friday, June, 6, 2025 HALO Chart by TradingView Halozyme Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/05/2025$53.85$53.55-0.56%$54.24$53.211.96 million shs$6.60 billion06/04/2025$53.31$53.85+1.01%$54.11$53.011.37 million shs$6.64 billion06/03/2025$55.64$53.31-4.19%$55.58$52.733.10 million shs$6.57 billion06/02/2025$55.98$55.64-0.61%$56.32$54.491.94 million shs$6.86 billion05/30/2025$54.73$55.98+2.28%$56.39$54.262.23 million shs$6.90 billion05/29/2025$54.43$54.73+0.55%$54.96$54.001.83 million shs$6.74 billion05/28/2025$54.42$54.43+0.02%$55.09$54.221.87 million shs$6.71 billion05/27/2025$54.54$54.42-0.22%$55.25$53.762.03 million shs$6.71 billion05/26/2025$54.54$54.54$54.68$53.031.20 million shs$6.72 billion05/23/2025$53.75$54.54+1.47%$54.68$53.031.20 million shs$6.72 billion Get the Latest News and Ratings for HALO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/22/2025$53.93$53.75-0.33%$54.19$53.041.44 million shs$6.62 billion05/21/2025$53.45$53.93+0.90%$54.26$52.431.97 million shs$6.65 billion05/20/2025$53.29$53.45+0.30%$53.95$52.771.77 million shs$6.59 billion05/19/2025$52.02$53.29+2.44%$53.37$51.752.23 million shs$6.57 billion05/16/2025$48.95$52.02+6.27%$52.75$48.643.98 million shs$6.41 billion05/15/2025$47.91$48.95+2.17%$49.70$47.743.66 million shs$6.03 billion05/14/2025$50.23$47.91-4.62%$50.25$47.507.16 million shs$5.90 billion05/13/2025$66.58$50.23-24.56%$57.99$48.1014.00 million shs$6.19 billion05/12/2025$65.86$66.58+1.09%$67.90$64.052.62 million shs$8.20 billion05/09/2025$67.71$65.86-2.74%$69.94$65.682.50 million shs$8.14 billion05/08/2025$70.05$67.71-3.34%$69.85$67.135.15 million shs$8.36 billion05/07/2025$59.38$70.05+17.97%$70.50$61.759.68 million shs$8.65 billion05/06/2025$60.62$59.38-2.05%$60.56$58.382.49 million shs$7.34 billion05/05/2025$61.19$60.62-0.93%$61.15$60.18905,972 shs$7.49 billion Related Companies BIIB Stock Chart UTHR Stock Chart INCY Stock Chart NBIX Stock Chart EXEL Stock Chart BMRN Stock Chart EXAS Stock Chart RGEN Stock Chart MDGL Stock Chart IONS Stock Chart Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HALO) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredThe Age of Chaos has begunThis is one of the most confusing markets in history. We have entered an Age of Chaos. And you must take...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HALO Stock Free HALO Stock Alerts